These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 12899749

  • 1. [Overexpression and genomic amplification of decoy receptor 3 in hepatocellular carcinoma and significance thereof].
    Shen HW, Wu YL, Peng SY.
    Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):744-7. PubMed ID: 12899749
    [Abstract] [Full Text] [Related]

  • 2. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Arakawa Y, Tachibana O, Hasegawa M, Miyamori T, Yamashita J, Hayashi Y.
    Acta Neuropathol; 2005 Mar 10; 109(3):294-8. PubMed ID: 15627206
    [Abstract] [Full Text] [Related]

  • 3. Expression of decoy receptor 3 in liver tissue microarrays.
    Chen G, Luo D.
    Natl Med J India; 2008 Mar 10; 21(6):275-8. PubMed ID: 19691215
    [Abstract] [Full Text] [Related]

  • 4. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1553-6. PubMed ID: 12609066
    [Abstract] [Full Text] [Related]

  • 5. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q, Liang LJ, Peng BG, Zhen YY.
    Ai Zheng; 2006 Nov 25; 25(11):1433-8. PubMed ID: 17094916
    [Abstract] [Full Text] [Related]

  • 6. Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.
    Chen C, Zhang C, Zhuang G, Luo H, Su J, Yin P, Wang J.
    Cancer Invest; 2008 Dec 25; 26(10):965-74. PubMed ID: 19093253
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of decoy receptor 3 in hepatocellular carcinoma and its association with resistance to Fas ligand-mediated apoptosis.
    Shen HW, Gao SL, Wu YL, Peng SY.
    World J Gastroenterol; 2005 Oct 14; 11(38):5926-30. PubMed ID: 16273601
    [Abstract] [Full Text] [Related]

  • 8. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L, Shen AG, Wang GL, Lu P, Li XY.
    Ai Zheng; 2006 Mar 14; 25(3):320-5. PubMed ID: 16536986
    [Abstract] [Full Text] [Related]

  • 9. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
    Cai S, Zhao H, Leng X, Cheng J, Gong S, Peng J, Cong X, Wang Y, Rui J, Hui Y, Du R, Chen W.
    Zhonghua Wai Ke Za Zhi; 2000 Sep 14; 38(9):693-6. PubMed ID: 11832142
    [Abstract] [Full Text] [Related]

  • 10. [WAF1/CIP1 gene expression in human hepatocellular carcinoma and its relationship with p53 mutation].
    Zhu B, Cong W, Wang H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Dec 14; 7(4):217-20. PubMed ID: 10715791
    [Abstract] [Full Text] [Related]

  • 11. [Expression and clinical significance of hepatocellular cancer antigen genes in human hepatocellular carcinoma].
    Wang WX, Leng XS, Peng JR, Mu DC, Wang Y, Zhu JY, Du RY, Chen WF.
    Zhonghua Wai Ke Za Zhi; 2003 Jul 14; 41(7):506-8. PubMed ID: 12921655
    [Abstract] [Full Text] [Related]

  • 12. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD, Zhao QC, Zhu YT, Zhang FQ, Dou KF.
    Zhonghua Wai Ke Za Zhi; 2006 Apr 01; 44(7):458-62. PubMed ID: 16772080
    [Abstract] [Full Text] [Related]

  • 13. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M, Hirooka Y, Kaibara N.
    Cancer; 2002 Nov 01; 95(9):1938-45. PubMed ID: 12404288
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.
    Pan HW, Ou YH, Peng SY, Liu SH, Lai PL, Lee PH, Sheu JC, Chen CL, Hsu HC.
    Cancer; 2003 Jul 01; 98(1):119-27. PubMed ID: 12833464
    [Abstract] [Full Text] [Related]

  • 15. Alternative mRNA splicing of liver intestine-cadherin in hepatocellular carcinoma.
    Wang XQ, Luk JM, Leung PP, Wong BW, Stanbridge EJ, Fan ST.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):483-9. PubMed ID: 15701831
    [Abstract] [Full Text] [Related]

  • 16. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L, Xi-Ran Z.
    Hepatogastroenterology; 2004 Jan 15; 51(56):515-25. PubMed ID: 15086194
    [Abstract] [Full Text] [Related]

  • 17. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y, Wu LQ, Lü ZH, Wang XJ, Yang JY.
    Chin Med J (Engl); 2007 Jun 20; 120(12):1042-6. PubMed ID: 17637219
    [Abstract] [Full Text] [Related]

  • 18. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
    Zhang WM, Xiao G, Xie D, Zhang M, Guo AL, Wen JM.
    Ai Zheng; 2005 May 20; 24(5):622-6. PubMed ID: 15890110
    [Abstract] [Full Text] [Related]

  • 19. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution.
    Hsu HC, Cheng W, Lai PL.
    Cancer Res; 1997 Nov 15; 57(22):5179-84. PubMed ID: 9371521
    [Abstract] [Full Text] [Related]

  • 20. [Expression of CXCR3 in hepatocellular carcinoma].
    Shi M, Guo RP, Zhang CQ, Zhong C, Lin XJ, Li JQ.
    Ai Zheng; 2006 Oct 15; 25(10):1232-7. PubMed ID: 17059766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.